Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ahmed Shayan Fazlur Rahman currently holds 1,647,388 shares of Adamis Pharmaceuticals Corp (ADMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ahmed Shayan Fazlur Rahman has been a net seller of ADMP stock. They have purchased $0 and sold $494.3K worth of shares.
Ahmed Shayan Fazlur Rahman's most recent insider trade was on Feb 12, 2015, when they sold 23,000 shares at $6.40 per share.
Ahmed Shayan Fazlur Rahman serves as Executive at Adamis Pharmaceuticals Corp (ADMP). They have executed 11 insider transactions totaling $494.3K over their tenure at the company.
Ahmed Shayan Fazlur Rahman holds the position of Executive at Adamis Pharmaceuticals Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Ahmed Shayan Fazlur Rahman has shown a selling trading pattern, with $0 in total purchases and $494.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ahmed Shayan Fazlur Rahman was on Feb 12, 2015, when they sold $147.2K worth of ADMP shares. This transaction involved 23,000 shares at $6.40 per share.
Ahmed Shayan Fazlur Rahman currently owns 1,647,388 shares of Adamis Pharmaceuticals Corp (ADMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ahmed Shayan Fazlur Rahman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ahmed Shayan Fazlur Rahman has 11 Form 4 filings on record as an insider at Adamis Pharmaceuticals Corp.
Set alerts for Ahmed Shayan Fazlur Rahman and 40,000+ other insiders.